Kanawha Capital Management’s Elevance Health ELV Stock Holding History

Kanawha Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-700	Closed	-$267K	–	201
2021 Q2	$267K	Sell	700 -16	-2%	-$6.11K	0.02%	189
2021 Q1	$257K	Sell	716 -3	-0.4%	-$965	0.03%	185
2020 Q4	$231K	Buy	+719	New	+$221K	0.02%	190
2020 Q1	–	Sell	-1,774	Closed	-$536K	–	182
2019 Q4	$536K	Buy	1,774 +27	+2%	+$7.43K	0.06%	128
2019 Q3	$419K	Buy	1,747 +71	+4%	+$19.5K	0.05%	142
2019 Q2	$473K	Hold	1,676	–	–	0.06%	133
2019 Q1	$481K	Sell	1,676 -450	-21%	-$130K	0.07%	123
2018 Q4	$558K	Hold	2,126	–	–	0.09%	111
2018 Q3	$583K	Hold	2,126	–	–	0.08%	107
2018 Q2	$506K	Hold	2,126	–	–	0.08%	117
2018 Q1	$467K	Sell	2,126 -500	-19%	-$117K	0.07%	122
2017 Q4	$591K	Hold	2,626	–	–	0.09%	107
2017 Q3	$499K	Hold	2,626	–	–	0.08%	119
2017 Q2	$494K	Hold	2,626	–	–	0.08%	120
2017 Q1	$434K	Hold	2,626	–	–	0.07%	129
2016 Q4	$378K	Hold	2,626	–	–	0.06%	132
2016 Q3	$329K	Hold	2,626	–	–	0.06%	141
2016 Q2	$345K	Hold	2,626	–	–	0.06%	140
2016 Q1	$365K	Buy	+2,626	New	+$351K	0.06%	132

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Kanawha Capital Management's ELV Position: Q3 2021 in Review

Kanawha Capital Management sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 700 shares — an estimated $267K sold.

Kanawha Capital Management first reported a position in ELV in Q1 2016 and held it in 19 quarters. The position peaked at $591K in Q4 2017. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

Kanawha Capital Management reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
Kanawha Capital Management sold 700 Elevance Health shares in Q3 2021, an estimated $267K.
Kanawha Capital Management first reported a position in Elevance Health in Q1 2016 and held it in 19 quarters.
Kanawha Capital Management's Elevance Health position peaked at $591K in Q4 2017.
1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Kanawha Capital Management's 13F filing for Q3 2021, filed 28 Oct 2021.